AdaptHealth revises FY24 revenue view to $ $3.22B-$3.26B, consensus $3.28B

The company is updating previous financial guidance for fiscal year 2024 as follows: Net revenue of $3.220B to $3.260B, from $3.255 B to $3.315B; Adjusted EBITDA of $655 million to $675 million, from $660 million to $700 million;Free cash flow of $175 million to $195 million, from $160 million to $180 million